Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 15.14 0.93% 0.14
ODT closed up 0.93 percent on Monday, December 10, 2018, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ODT trend table...

Date Alert Name Type % Chg
Dec 10 Inside Day Range Contraction 0.00%
Dec 10 Oversold Stochastic Weakness 0.00%
Dec 7 Stochastic Reached Oversold Weakness 0.93%
Dec 7 Oversold Stochastic Weakness 0.93%
Dec 6 MACD Bearish Signal Line Cross Bearish 3.98%
Dec 4 20 DMA Resistance Bearish -1.11%
Dec 4 50 DMA Resistance Bearish -1.11%
Dec 4 Outside Day Range Expansion -1.11%
Dec 3 Pocket Pivot Bullish Swing Setup -4.12%
Nov 30 50 DMA Resistance Bearish -3.93%

Older signals for ODT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2018-10-29
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $258,967 of Shares
Nov 9 Consolidated Research: 2018 Summary Expectations for Senior Housing Properties Trust, NACCO Industries, Primo Water, Martin Marietta Materials, Iamgold, and Odonate Therapeutics — Fundamental Analysis, Key Performance Indications
Nov 6 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $148,700 of Shares
Nov 5 74 Biggest Movers From Friday
Oct 30 Odonate Therapeutics: Insiders Buying This Oncology Concern
Oct 30 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $153,320 of Shares
Oct 26 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $610,393 of Shares
Oct 23 The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares
Oct 23 Odonate Therapeutics misses by $0.02
Oct 23 Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018
See more ODT news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 14.06
Average Volume 51,409
200-Day Moving Average 20.9161
50-Day Moving Average 16.1424
20-Day Moving Average 15.7925
10-Day Moving Average 15.508
Average True Range 1.1453
ADX 14.43
+DI 17.5116
-DI 19.3868
Chandelier Exit (Long, 3 ATRs ) 14.7341
Chandelier Exit (Short, 3 ATRs ) 17.8259
Upper Bollinger Band 17.2417
Lower Bollinger Band 14.3433
Percent B (%b) 0.27
BandWidth 18.353016
MACD Line -0.3417
MACD Signal Line -0.2783
MACD Histogram -0.0634
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.27
Resistance 3 (R3) 16.24 15.85 16.08
Resistance 2 (R2) 15.85 15.56 15.86 16.01
Resistance 1 (R1) 15.49 15.38 15.30 15.52 15.95
Pivot Point 15.10 15.10 15.00 15.11 15.10
Support 1 (S1) 14.74 14.81 14.55 14.77 14.33
Support 2 (S2) 14.35 14.63 14.36 14.27
Support 3 (S3) 13.99 14.35 14.20
Support 4 (S4) 14.02